NCT06620159

Lymphocyte to Procalcitonin Ratio in Covid-19 Patients

Lymphocyte to Procalcitonin Ratio: A New Predictor of Prognosis and Mortality in Covid

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 535 (actual)
• Sponsor: Suleyman Demirel University · Academic / Other
• Sex: All
• Age: 23 Years – 100 Years
• Healthy volunteers: Not accepted

Summary

The lymphocyte/CRP ratio has been studied many times in covid-19 patients and has been proven to be an indicator of mortality as well as poor prognosis. In this study, the role of the lymphocyte/procalcitonin ratio in predicting the hospitalization status of patients, detection of findings on CT, need for mechanical ventilation, mortality and survival is aimed to be determined. The lymphocyte/procalcitonin ratio was found to be the strongest predictor of mortality and poor prognosis, especially in patients over 65 years of age.

Detailed description

The lymphocyte/CRP ratio has been studied many times in covid-19 patients and has been proven to be an indicator of mortality as well as poor prognosis. In this study, the role of the lymphocyte/procalcitonin ratio in predicting the hospitalization status of patients, detection of findings on CT, need for mechanical ventilation, mortality and survival is aimed to be determined. The lymphocyte/procalcitonin ratio was found to be the strongest predictor of mortality and poor prognosis, especially in patients over 65 years of age. The auc value, PPV and specificity of the lymphocyte/procalcitonin ratio were higher than the lymphocyte/CRP ratio.

Conditions

• COVID-19

Timeline

• Start date: 2020-04-01
• Primary completion: 2024-09-27
• Completion: 2024-12-01
• First posted: 2024-10-01
• Last updated: 2024-10-03

Locations

1 site across 1 country: Turkey (Türkiye)